Systematic Light Exposure in Pediatric Brain Tumor Survivors

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 14, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions
Brain Tumor
Interventions
BEHAVIORAL

Bright Light Exposure

Research coordinator will follow-up with participant on Days 2 \& 5, and weekly thereafter to assess for the presence of potential side effects. If side effects are present with bright light initiation and they do not resolve by Day 5, the intervention will be discontinued.

BEHAVIORAL

Dim Light Exposure

A placebo pair of glasses that is identical in form to the bright light glasses with the exception of light intensity will be used in a manner identical to the bright light glasses.

OTHER

Cognitive Assessment

Cognitive examinations will be completed in-person and remotely via an online platform; caregivers and participants will also be asked to complete questionnaires assessing fatigue, sleep, and mood. These outcomes will be completed at baseline (prior to intervention/placebo), Week 4, Week 6 (end of intervention/placebo), and Week 8 (2-weeks post intervention/placebo).

Trial Locations (1)

77030

RECRUITING

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

collaborator

St. Jude Children's Research Hospital

OTHER

lead

Baylor College of Medicine

OTHER